Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Maxcyte (MXCT) Depreciation & Amortization (IS) (2021 - 2026)

Maxcyte has reported Depreciation & Amortization (IS) over the past 5 years, most recently at $1.0 million for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) rose 2.06% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, up 2.0% year-over-year, with the annual reading at $4.2 million for FY2025, 2.0% up from the prior year.
  • Depreciation & Amortization (IS) was $1.0 million for Q4 2025 at Maxcyte, roughly flat from $1.0 million in the prior quarter.
  • Over five years, Depreciation & Amortization (IS) peaked at $1.1 million in Q2 2025 and troughed at $311600.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (IS) is $998500.0 (2023), against an average of $811555.0.
  • Year-over-year, Depreciation & Amortization (IS) skyrocketed 128.96% in 2022 and then decreased 4.05% in 2024.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $381600.0 in 2021, then skyrocketed by 128.96% to $873700.0 in 2022, then rose by 21.67% to $1.1 million in 2023, then dropped by 4.05% to $1.0 million in 2024, then rose by 2.06% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Depreciation & Amortization (IS) are $1.0 million (Q4 2025), $1.0 million (Q3 2025), and $1.1 million (Q2 2025).